Cargando…

Corrigendum: Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-Small-Cell Lung Cancer

Detalles Bibliográficos
Autores principales:	Gan, Junqing, Meng, Qingwei, Li, Yanjing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078412/ https://www.ncbi.nlm.nih.gov/pubmed/33928124 http://dx.doi.org/10.3389/fmolb.2021.653454

Ejemplares similares

Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-small-Cell Lung Cancer
por: Gan, Junqing, et al.
Publicado: (2020)

Systematic analysis of expression profiles of HMGB family members for prognostic application in non-small cell lung cancer
por: Zheng, Xuefeng, et al.
Publicado: (2022)

FAM family gene prediction model reveals heterogeneity, stemness and immune microenvironment of UCEC
por: Chi, Hao, et al.
Publicado: (2023)

Clinical Prognostic Value of the PLOD Gene Family in Lung Adenocarcinoma
por: Meng, Yiming, et al.
Publicado: (2022)

Functions and evolution of FAM111 serine proteases
por: Welter, Allison L., et al.
Publicado: (2022)

Comprehensive analysis of the expression, prognostic significance, and function of FAM83 family members in breast cancer
por: Jin, Yi, et al.
Publicado: (2022)

Significance of Parkinson Family Genes in the Prognosis and Treatment Outcome Prediction for Lung Adenocarcinoma
por: Li, Yanqi, et al.
Publicado: (2021)

FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
por: Richtmann, Sarah, et al.
Publicado: (2019)

Fam20C in Human Diseases: Emerging Biological Functions and Therapeutic Implications
por: Xu, Rongsheng, et al.
Publicado: (2021)

AVEN: a novel oncogenic biomarker with prognostic significance and implications of AVEN-associated immunophenotypes in lung adenocarcinoma
por: Fan, Dengxia, et al.
Publicado: (2023)

FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma
por: Wang, Gaoming, et al.
Publicado: (2021)

Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
por: Zhang, Xiaoyu, et al.
Publicado: (2021)

Comprehensive pan-cancer investigation: unraveling the oncogenic, prognostic, and immunological significance of Abelson interactor family member 3 gene in human malignancies
por: Sun, Aijun, et al.
Publicado: (2023)

Prognostic significance of FAM83D gene expression across human cancer types
por: Walian, Peter J., et al.
Publicado: (2015)

Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Comprehensive Analyses of Ferroptosis-Related Alterations and Their Prognostic Significance in Glioblastoma
por: Tian, Yuan, et al.
Publicado: (2022)

A tumor microenvironment gene set–Based prognostic signature for non-small-cell lung cancer
por: Wen, Yingsheng, et al.
Publicado: (2022)

Expression Characteristics and Significant Prognostic Values of PGK1 in Breast Cancer
por: Li, Yanping, et al.
Publicado: (2021)

Corrigendum: Isoform Age - Splice Isoform Profiling Using Long-Read Technologies
por: De Paoli-Iseppi, Ricardo, et al.
Publicado: (2021)

Corrigendum: Exercise blood-drop metabolic profiling links metabolism with perceived exertion
por: Opialla, Tobias, et al.
Publicado: (2023)

SYDE1 Acts as an Oncogene in Glioma and has Diagnostic and Prognostic Values
por: Han, Zhenyuan, et al.
Publicado: (2021)

Integrative Analyses and Verification of the Expression and Prognostic Significance for RCN1 in Glioblastoma Multiforme
por: Lu, Weicheng, et al.
Publicado: (2021)

Expression and Prognostic Value of MCM Family Genes in Osteosarcoma
por: Zhou, Jian, et al.
Publicado: (2021)

Development and Validation of Novel Prognostic Models for Immune-Related Genes in Osteosarcoma
por: Li, Junqing, et al.
Publicado: (2022)

Integrated Analysis of Transcriptomic and Genomic Data Reveals Blood Biomarkers With Diagnostic and Prognostic Potential in Non-small Cell Lung Cancer
por: Kaya, Ibrahim H., et al.
Publicado: (2022)

Over-Expression and Prognostic Significance of FATP5, as a New Biomarker, in Colorectal Carcinoma
por: Geng, Qi-Shun, et al.
Publicado: (2022)

Diagnostic, Therapeutic, and Prognostic Value of the Thrombospondin Family in Gastric Cancer
por: Lu, Yi, et al.
Publicado: (2021)

Prognostic and immunotherapeutic significance of mannose receptor C type II in 33 cancers: An integrated analysis
por: Zhao, Zhixun, et al.
Publicado: (2022)

Corrigendum: The Immune System in Transfusion-Related Acute Lung Injury Prevention and Therapy: Update and Perspective
por: Guo, Kai, et al.
Publicado: (2021)

LncRNA FAM13A-AS1 Promotes Renal Carcinoma Tumorigenesis Through Sponging miR-141-3p to Upregulate NEK6 Expression
por: Wang, Xin Jun, et al.
Publicado: (2022)

Long noncoding antisense RNA FAM83A‐AS1 promotes lung cancer cell progression by increasing FAM83A
por: Shi, Rongxing, et al.
Publicado: (2019)

Identification of a Prognostic Signature Associated With the Homeobox Gene Family for Bladder Cancer
por: Dong, Bingqi, et al.
Publicado: (2021)

A comprehensive prognostic and immunological analysis of ephrin family genes in hepatocellular carcinoma
por: Huang, Shenglan, et al.
Publicado: (2022)

Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2022)

Identification of therapeutic targets and prognostic biomarkers among frizzled family genes in glioma
por: Huang, Ke, et al.
Publicado: (2023)

Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma
por: Ma, Zuyi, et al.
Publicado: (2021)

Identification of Key Genes in Lung Adenocarcinoma and Establishment of Prognostic Mode
por: Jiawei, Zhou, et al.
Publicado: (2020)

Prognostic Implications and Immune Infiltration Characteristics of Chromosomal Instability-Related Dysregulated CeRNA in Lung Adenocarcinoma
por: Guo, Shengnan, et al.
Publicado: (2022)

Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma
por: Liu, Xin, et al.
Publicado: (2022)

Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma
por: Zhang, Jing-Tao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h1kvns182rea2g3nfh15q9tp7i